Travere Therapeutics (TVTX) Total Non-Current Liabilities (2011 - 2026)
Travere Therapeutics (TVTX) posted Total Non-Current Liabilities of $762.77 million for Q2 2026, up 48.2% from $514.68 million a year earlier and up 70.6% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics' Total Non-Current Liabilities came in at $482.76 million, down 8.6% from FY2024.
- Annual Total Non-Current Liabilities has declined for three consecutive years, though with a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- In prior years, Travere Therapeutics' Total Non-Current Liabilities was $528.25 million in FY2024 (-8.6%), $577.78 million in FY2023 (-6.9%), $620.35 million in FY2022 (+52.3%) and $407.42 million in FY2021 (+23.0%).
- The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2011.
- On a year-over-year basis, Total Non-Current Liabilities increased in 1 of the last eight quarters, with an average decline of 1.2%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2022, with growth of 52.6%; the weakest was Q1 2026, with a decline of 12.1%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $447.08 million (Q1 2026), $482.76 million (Q4 2025) and $459.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Travere Therapeutics | 4.94 Bn | 4.54 Bn | 167.41 Mn | 762.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 762.77 Mn |
| Mar 31, 2026 | 447.08 Mn |
| Dec 31, 2025 | 482.76 Mn |
| Sep 30, 2025 | 459.09 Mn |
| Jun 30, 2025 | 514.68 Mn |
| Mar 31, 2025 | 508.70 Mn |
| Dec 31, 2024 | 528.25 Mn |
| Sep 30, 2024 | 518.58 Mn |
| Jun 30, 2024 | 519.33 Mn |
| Mar 31, 2024 | 573.10 Mn |
| Dec 31, 2023 | 577.78 Mn |
| Sep 30, 2023 | 544.70 Mn |
| Jun 30, 2023 | 469.91 Mn |
| Mar 31, 2023 | 466.52 Mn |
| Dec 31, 2022 | 620.35 Mn |
| Sep 30, 2022 | 471.14 Mn |
| Jun 30, 2022 | 469.08 Mn |
| Mar 31, 2022 | 470.41 Mn |
| Dec 31, 2021 | 335.45 Mn |
| Sep 30, 2021 | 424.44 Mn |
API Access
Travere Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();